Skip To Content

Determining the Site of Modification … Part 3

September 8, 2009
by Arvin Moser, Team Manager, Application Scientists, ACD/Labs

Tandem mass spectrometry involves the process of selecting and separating a product ion(s) (or daughter ion(s)) and fragmenting it in a second mass analyzer. This is commonly referred to as MS/MS or MS2. Additional tandem processes can be applied to ions in the MS/MS data to create MS3 data, and so forth.

The metabolites A and B share the same exact mass, and as such, cannot be differentiated by the MS data alone (see Part 1 of this series). The MS/MS data, described in Part 2, offers fragment information that can assist in eliminating one of the candidates. Taking it a step further and thus verifying the candidate metabolite A, ESI+ MS3 data is presented herein.

The fragmentation scheme below shows both the Parent and Metabolite A with the fragment at 121 Da, in bold, fragmenting to create a fragment at 93 Da. This is supported by the nearly-identical MS3 data displayed below.

MS2CompareToAPI_Part3Frag_Sept82009 MS2CompareToAPI_Part3MS3_121_Sept82009

On the right-hand side of the fragmentation scheme, the fragments 106 and 108 Da are expected for the MS3 data of the Parent and Metabolite A, respectively.

MS2CompareToAPI_Part3MS3_134_Sept82009

Join our newsletter!

Keep up-to-date with our quarterly newsletter that brings you the latest educational webinars, resources, tips, and tricks.

This field is for validation purposes and should be left unchanged.

Comments

Your email address will not be published. Required fields are marked *

Join our newsletter!

Keep up-to-date with our quarterly newsletter that brings you the latest educational webinars, resources, tips, and tricks.

This field is for validation purposes and should be left unchanged.